Dr. Matthew J. Reilley
Claim this profileUniversity of Virginia Cancer Center
Area of expertise
Cancer
Matthew J. Reilley has run 7 trials for Cancer. Some of their research focus areas include:
Pancreatic Cancer
Matthew J. Reilley has run 7 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Virginia Cancer Center
University Of Virginia
Clinical Trials Matthew J. Reilley is currently running
NDI-219216
for Cancer
The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in the later phases of the study. The main questions it aims to answer are: Is NDI-219216 safe and what kinds of side effects might it cause? What kind of effects does NDI-219216 have on the body? Does NDI-219216 have any impact on tumor size? Participants will: Take NDI-219216 every day by mouth. Visit the clinic 6 times during Cycle 1, 2 times during Cycle 2, once a month thereafter for checkups and tests while on the study, then one time for an end of treatment visit. After the End of Study, a follow up will occur but can be done on the phone. Keep a diary of their tablet consumption and symptoms experienced.
Recruiting
1 award
Phase 1 & 2
2 criteria
Durvalumab + Chemotherapy
for Bile Duct Cancer
This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectable). Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving durvalumab with gemcitabine and cisplatin before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed in patients with high risk resectable cholangiocarcinoma.
Recruiting
1 award
Phase 2
More about Matthew J. Reilley
Clinical Trial Related
1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Matthew J. Reilley has experience with
- Oxaliplatin
- Fluorouracil
- Binimetinib
- Palbociclib
- Pembrolizumab
- Leucovorin
Breakdown of trials Matthew J. Reilley has run
Cancer
Pancreatic Cancer
Solid Tumors
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew J. Reilley specialize in?
Matthew J. Reilley focuses on Cancer and Pancreatic Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Matthew J. Reilley currently recruiting for clinical trials?
Yes, Matthew J. Reilley is currently recruiting for 5 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Matthew J. Reilley has studied deeply?
Yes, Matthew J. Reilley has studied treatments such as Oxaliplatin, Fluorouracil, Binimetinib.
What is the best way to schedule an appointment with Matthew J. Reilley?
Apply for one of the trials that Matthew J. Reilley is conducting.
What is the office address of Matthew J. Reilley?
The office of Matthew J. Reilley is located at: University of Virginia Cancer Center, Charlottesville, Virginia 22908 United States. This is the address for their practice at the University of Virginia Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.